相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse
Karinna Almodovar et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Chemoradiotherapy-induced hemoglobin nadir values and survival in patients with stage III non-small cell lung cancer
Erkan Topkan et al.
LUNG CANCER (2018)
Immune checkpoint inhibitors in small cell lung cancer
Suchita Pakkala et al.
JOURNAL OF THORACIC DISEASE (2018)
Clinical correlation of extensive-stage small-cell lung cancer genomics
A. Dowlati et al.
ANNALS OF ONCOLOGY (2016)
Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?
Paul A. Bunn et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial
Koichi Goto et al.
LANCET ONCOLOGY (2016)
Overall Response Rate, Progression-Free Survival, and Overall Survival With Targeted and Standard Therapies in Advanced Non-Small-Cell Lung Cancer: US Food and Drug Administration Trial-Level and Patient-Level Analyses
Gideon M. Blumenthal et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients
Nobuyuki Horita et al.
Scientific Reports (2015)
Differential regulation of MMPs by E2F1, Sp1 and NF-kappa B controls the small cell lung cancer invasive phenotype
Zunling Li et al.
BMC CANCER (2014)
Southwest Oncology Group S0802: A Randomized, Phase II Trial of Weekly Topotecan With and Without Ziv-Aflibercept in Patients With Platinum-Treated Small-Cell Lung Cancer
Jeffrey W. Allen et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy
Ross A. Soo et al.
FUTURE ONCOLOGY (2012)
Efficacy and Toxicity of Belotecan for Relapsed or Refractory Small Cell Lung Cancer Patients
Gun Min Kim et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
A Systematic Analysis of Efficacy of Second-Line Chemotherapy in Sensitive and Refractory Small-Cell Lung Cancer
Taofeek K. Owonikoko et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin
Martin Reck et al.
LUNG CANCER (2012)
Outcomes in recurrent small-cell lung cancer after one to four chemotherapy lines: A retrospective study of 300 patients
Helene Nagy-Mignotte et al.
LUNG CANCER (2012)
A multicenter phase II study of belotecan, a new camptothecin analogue, as a second-line therapy in patients with small cell lung cancer
Chin Kook Rhee et al.
LUNG CANCER (2011)
Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: A phase II trial
Jaeheon Jeong et al.
LUNG CANCER (2010)
Progression-Free Survival Is Simply a Measure of a Drug's Effect While Administered and Is Not a Surrogate for Overall Survival
Julia Wilkerson et al.
CANCER JOURNAL (2009)
Characterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosis
Dianke Yu et al.
CLINICAL CANCER RESEARCH (2008)
Current status of second-line treatment and novel therapies for small cell lung cancer
Marcello Tiseo et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
The impact of anemia on outcome of chemoradiation for limited small-cell lung cancer: a combined analysis of studies of the National Cancer Institute of Canada Clinical Trials Group
S. A. Laurie et al.
ANNALS OF ONCOLOGY (2007)
Treatment of small cell lung cancer in the elderly
A Rossi et al.
ONCOLOGIST (2005)
Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia
JJ Laskin et al.
LUNG CANCER (2004)
Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy
SJP Van Belle et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2003)
Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity
Y Xu et al.
ANNALS OF ONCOLOGY (2002)
分享论文
